Drug-Associated Eosinophilic Fasciitis: A Case of Eosinophilic Fasciitis Secondary to Cemiplimab Therapy

Sri Harsha Boppana; Nageswara Rao Dulla; Bryce D. Beutler; Nageshwara Gullapalli; Ratinder Kaur

doi:10.12659/AJCR.932888

17 August 2021 : Case report USA

Drug-Associated Eosinophilic Fasciitis: A Case of Eosinophilic Fasciitis Secondary to Cemiplimab Therapy

Challenging differential diagnosis, Unusual or unexpected effect of treatment, Unexpected drug reaction, Rare disease, Clinical situation which can not be reproduced for ethical reasons

Sri Harsha Boppana^1A*, Nageswara Rao Dulla^2EF, Bryce D. Beutler^3EF, Nageshwara Gullapalli^1ADEFG, Ratinder Kaur^14DE

DOI: 10.12659/AJCR.932888

Am J Case Rep 2021; 22:e932888

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

View HTML version

Figure 3. Septa showing mononuclear infiltrate and scant eosinophils (hematoxylin and eosin staining; 400×).

Back to the Article

Drug-Associated Eosinophilic Fasciitis: A Case of Eosinophilic Fasciitis Secondary to Cemiplimab Therapy

Your Privacy